Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hangzhou Facecare Cosmetics Co., Ltd.
WARNING LETTER
•Hangzhou Facecare Cosmetics Co., Ltd.•June 22, 2017

Hangzhou Facecare Cosmetics Co., Ltd. – FDA Warning Letter, Jun 22, 2017

Record Details

The FDA issued a Warning Letter to Hangzhou Facecare Cosmetics Co., Ltd. following a June 19-22, 2017, inspection, citing significant CGMP violations for finished pharmaceuticals, rendering their drug products adulterated.

Key violations include: 1. **Failure to test finished drug products:** The firm released OTC drug products without adequate acceptance testing for conformance to specifications, including identity and strength (21 CFR 211.165(a)). 2. **Inadequate component testing:** The firm did not adequately test incoming active pharmaceutical ingredients and other components for identity, purity, strength, and quality (21 CFR 211.84(d)(1),(2)). 3. **Unsupported expiration dates:** OTC drug products shipped to the U.S. lacked expiration dates, and no stability data supported their shelf lives (21 CFR 211.137(a)).

The firm's July 12, 2017, response was deemed inadequate, lacking sufficient evidence of corrective actions, including specific test methods, comprehensive test results for products and components, procedures for contract facility oversight, stability data, and a comprehensive CGMP assessment with a CAPA plan.

The FDA strongly recommended engaging a qualified CGMP consultant. The firm, as a contract manufacturer, is responsible for the quality of drugs produced. The FDA placed the firm on Import Alert 66-4

Company
Hangzhou Facecare Cosmetics Co., Ltd.
Inspection date
June 22, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 8eecae36-b8c9-465d-810b-c1b4a8dd291b

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.165(a)21 CFR 211.84(d)(1)21 CFR 211.84(d)(2)21 CFR 211.137(a)FD&C Act 501(a)(2)(B)FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Hangzhou Facecare Cosmetics Co., Ltd.
  • 483 - 2019-04-05April 5, 2019
  • 483 - 2017-06-19June 19, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hangzhou Facecare Cosmetics Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.